Kane Biotech Announces Special Meeting of Shareholders
WINNIPEG, Manitoba, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company”, “Kane” or “Kane Biotech”) announces...
Pharmaceutical
Genix Announces Warrant Repricing and Seeks Extension
Vancouver, British Columbia--(Newsfile Corp. - January 18, 2024) - Genix Pharmaceuticals Corporation (TSXV: GENX) (OTCQB: GENPF) ("GENIX" or the "Company")...
CORRECTION BY SOURCE: Solta Medical’s Thermage(R) FLX and TR-4 Return Pad Receive Registration Certifications in China
Approval Represents an Important Breakthrough in One of the Largest Medical Aesthetics Markets(*CORRECTION to the release that was posted earlier...
Cosmos Health Bolsters Presence in $400Bn+ Global Generic Drugs Market with $3.5M Acquisition of 10-Drug Portfolio
CHICAGO, IL / ACCESSWIRE / January 18, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified,...
GE HealthCare to Announce Fourth Quarter and Full Year 2023 Results on February 6, 2024
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC), a leader in precision care innovation, will announce its fourth quarter and full year 2023...
Biotech Commercialization Leader, Amy Mahery, to Join CNS Pharmaceuticals Board of Directors
Highly accomplished biopharmaceutical industry executive with successful track record in the commercialization and launch of drugs in varied therapeutic areas...
Solta Medical’s Thermage(R) FLX and TR-4 Return Pad Receive Registration Certifications in China
Approval Represents an Important Breakthrough in One of the Largest Medical Aesthetics MarketsLAVAL, QC / ACCESSWIRE / January 18, 2024...
Genflow Biosciences PLC Announces Two Non-Dilutive Research Grant Awards
Secures Two Research Grants from Belgium's New Technological Innovation PartnershipLONDON, UK / ACCESSWIRE / January 18, 2024 / The Company...
Envision Pharma Group Welcomes Industry Veteran and HR Expert Carolyn Bartholdson as Chief People Officer
Carolyn's strategic vision and experience will be integral to securing and creating top talent to advance Envision's priorities.FAIRFIELD, CT /...
Elevar Therapeutics To Present Two Posters From Phase 3 CARES-310 Study at 2024 ASCO Gastrointestinal Cancers Symposium
A post hoc analysis found the efficacy of camrelizumab plus rivoceranib was superior to sorafenib regardless of baseline liver function...
XOMA Expands its Commercial Royalty and Milestone Portfolio with DSUVIA® Acquisition
XOMA provided an $8 million non-dilutive royalty capital solution to Talphera XOMA will receive a 15% royalty on all commercial...
Adial Announces Appointment of Tony Goodman as Chief Operating Officer
Highly Experienced Pharma Commercial and Business Development Executive in Addiction Treatment Space Joins Leadership Team While Continuing as Board MemberCharlottesville,...
UK’s largest independent chemical manufacturer takes drug testing in-house with Intelligent Fingerprinting Drug Screening System
NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical...
The Government Draws Attention to Swedish Alzheimer’s Research and Together with the Swedish Alzheimer’s Foundation Visit AlzeCure Pharma
STOCKHOLM, SWEDEN / ACCESSWIRE / January 17, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical...
AMC Health Announces Dr. Zebadiah Kimmel, MD, MBA, as Chief Product Officer
Dr. Kimmel brings more than 15 years of leadership to AMC HealthNEW YORK, NY / ACCESSWIRE / January 17, 2024...
CNS Pharmaceuticals Achieves Completion of Planned Enrollment in Potentially Pivotal Study of Berubicin for the Treatment of Glioblastoma Multiforme (GBM)
HOUSTON, TX / ACCESSWIRE / January 17, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company...
NurExone and Inteligex Kick Off Chronic Spinal Cord Injury Research for Multi-Billion Dollar Healthcare Market
TORONTO and HAIFA, Israel, Jan. 17, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (FSE: J90) (NRX.V) (the “Company”...
Enlivex Receives IMOH Regulatory Authorization for the Initiation of a Multi-Country, Randomized, Controlled Phase I/II Trial Evaluating Allocetra in Up To 160 Patients with Moderate to Severe Knee Osteoarthritis
Second study of Allocetra in knee osteoarthritis, following the on-going Phase I/II trial in pre-surgery, end-stage osteoarthritis, that is continuing...
Daré Bioscience Announces Grant to Support Biotherapeutic Product Development
Grant funds support activities that will aid the ultimate development of bacteria-based biotherapeutic products designed to benefit women and newbornsSAN...
Windtree Therapeutics Announces License Agreement with Lee’s Pharmaceuticals to Develop and Commercialize Istaroxime, Dual Mechanism SERCA2a Activators and Rostafuroxin for Greater China / Asia Pacific Region
Windtree to receive potential future milestones up to $138MM plus up to low double digit royalties and full coverage for...